高原地区舒血宁联合葛根素治疗急性缺血性脑卒中的疗效观察  

Study of the Curative Effect on Shuxuening Combination with Puerarin in the Treatment of Acute Ischemic Stroke

作　　者：姚小军[1] 白冬梅[1] 文军宝[1] 王晨[1] 孙成都 

机构地区：[1]解放军第22医院神经内科,青海格尔木816000

出　　处：《临床军医杂志》2009年第3期375-377,共3页Clinical Journal of Medical Officers

摘　　要：目的观察舒血宁联合葛根素治疗急性缺血性脑卒中的疗效。方法选择急性缺血性脑卒中患者120名,随机分为舒血宁联合葛根素治疗组(简称治疗组60例)与葛根素组(简称对照组60例),在其余治疗基本相同的情况下,进行临床疗效观察。结果治疗组总有效率95.0%,临床治愈率31.7%;对照组总有效率76.7%,临床治愈率16.7%;治疗组与对照组的总有效率及临床治愈率比较差异均有统计学意义(P<0.05)。结论葛根素联合舒血宁治疗急性缺血性脑卒中有较好的疗效,无明显不良反应。Objective To observe the clinical curative effects of Puerarin combination with Shuxuening injection in the treatment of acute ischemic stroke. Methods 120 patients with acute ischemic stroke were randomly divided into 2 groups：Puerarin combination with Shuxuening injection group （treatment group including 60 cases） and Puerarin group（control group including 60 cases）. Clinical curative effects were inspected and the results were dealt with statistical analysis. Results The effective rate of acute ische- mic stroke patients was 95.0% in thetreatment group and 76.7% in the control group, with significant difference between them（P 〈 0.05 ） . The clinical curative effect difference between the two groups was significant too（31.7% vs 16.7% ,P 〈 0.05 ） Conclusion Puerarin combination with shuxuening injection is a better treatment project for acute ischemic stroke without obvious side effect.

关 键 词：葛根素 舒血宁 缺血性脑卒中 治疗 

分 类 号：R743.33[医药卫生—神经病学与精神病学]